Long-term follow-up of patients with chronic hepatitis B after interferon treatment

Zeitschrift fur Gastroenterologie

Volumn 34, Issue 4, 1996, Pages 230-236

  Teuber, G ^a   Dienes, H P ^a   Meyer Zum Buschenfelde K H ^a   Gerken, G ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

chronic hepatitis B; cirrhosis; interferon treatment

Indexed keywords

ALPHA INTERFERON; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS, CHRONIC; HUMANS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER; LIVER CIRRHOSIS; LONG-TERM CARE; MALE; MIDDLE AGED; SURVIVAL RATE;

EID: 0029929277     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Margolis HS, Alter MJ, Hadler SC. Hepatitis B. Evolving epidemiology and implication of control. Sem Liver Dis 1991; 11: 84-92
2. Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 1335-9
3. Wright LT, Lau JYN: Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 1340-4
4. Fattovich G, Brullo L, Giustina G et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-8
5. Davis GL. Treatment of chronic hepatitis B. (Editorial). Hepatology 1991; 14: 567-9
6. Weissberg JI, Andres LL, Smith CI et al. Survival in chronic hepatitis B. Ann Intern Med 1984; 101: 613-6
7. De Jongh FE, Janssen HLA, De Man RA et al Survival and prognostic indicators in hepatitis B surface antigen positive cirrhosis of the liver. Gastroenterology 1992; 103: 1630-5
8. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology 1991; 13: 627-31
9. Poralla T, Manns M, Hüttenroth TH et al HBsAg clearance in patients with long standing chronic active hepatitis B and hepatitis B virus induced liver cirrhosis. Digestion 1986; 33: 33-9
10. Hoofnagle JH, Dusheiko GM, Seeff LB et al. Sero-conversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Int Med 1981; 94: 744-8
11. Lok ASF, Lai C-L, Wu P-C, Leung EKY, Lam T-S. Spontaneous hepatitis B e anti-gen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 1987; 92: 1839-43
12. Davis GL, Hoofnagel JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984; 86: 230-5
13. Perillo RP, Schiff ER, Davis GL et al. A randomized, controlled trial of Interferon alfa-2b alone and after prednisone with-drawal for the treatment of chronic hepatitis B. N Engl J Med 1990, 323: 295-301
14. Perillo RP. Interferon in the management of chronic hepatitis B Dig Dis Sci 1993; 38: 577-93
15. Wong DKH, Cheung AM, O'Rourke K et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A metaanaylsis. Ann Intern Med 1993; 119: 312-23
16. Tine F, Liberati A, Craxi A, Almasio P, Pagliaro L. Interferon treatment in patients with chronic hepatits B: A meta-analysis of the published literature. J Hepatol 1993; 18. 154-62
17. Krogsgaard K, Bindslev N, Christensen E et al. and the european concerted action on viral hepatitis (Eurohep). The treatment effect of alpha Interferon in chronic hepatitis B is independent of pretreatment variables. Results based on individual patient data from 10 clinical controlled trials. J Hepatol 1994; 21: 646-55
18. Korenman J, Baker B, Waggoner J et al. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann intern Med 1991; 114: 629-34
19. Carreno V, Castillo I, Molina J, Porres JC, Bartolomé J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992; 15 102-6
20. Lok ASF, Chung H-T, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993; 105: 1833-8
21. Santantonio T, Jung MC, Monno L et al. Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity. Arch Virol 1993 (suppl.) 8: 171-8
22. Carreno V, Bartolomé J, Castillo I. Long-term effect of interferon therapy in chronic hepatitis B. J Hepatol 1994; 20: 431-8
23. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer P Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-20
24. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transsection of the oesophagus for bleeding oesophageal varices. Brit J Surg 1973; 60: 646-9
25. Gerken G, Gerlich WH, Bréchot C et al. Biological standards for hepatitis B virus assays. J Hepatol 1992; 15: 251-5
26. Goergen B, Meyer zum Büschenfelde KH, Gerken G Mutation specific PCR and direct solid phase sequencing assay for the detection of hepatitis B virus Pre-C/C mutants in anti-HBe-positive, chronic hepatitis B. J Med Virol 1994; 43: 97-102
27. Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B Gastroenterology 1993; 104. 1116-21
28. Nevens F, Goubau P, Van Eyken P et al. Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha. Liver 1993; 13: 15-19